GLECAPREVIR 100 MG / PIBRENTASVIR 40 MG ORAL TABLET [MAVYRET]

Side Effects & Adverse Event Reports


View Chart Data

10.7K

Adverse Events

22.9K

Side Effects

2025

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on GLECAPREVIR 100 MG / PIBRENTASVIR 40 MG ORAL TABLET [MAVYRET].

Understanding the potential Side Effects and Adverse Events of GLECAPREVIR 100 MG / PIBRENTASVIR 40 MG ORAL TABLET [MAVYRET] is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how GLECAPREVIR 100 MG / PIBRENTASVIR 40 MG ORAL TABLET [MAVYRET] may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about GLECAPREVIR 100 MG / PIBRENTASVIR 40 MG ORAL TABLET [MAVYRET] are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for GLECAPREVIR 100 MG / PIBRENTASVIR 40 MG ORAL TABLET [MAVYRET]?

    GLECAPREVIR 100 MG / PIBRENTASVIR 40 MG ORAL TABLET [MAVYRET] has 10,701 adverse event reports in this SymPedia dataset.

  • How many side effects have been reported for GLECAPREVIR 100 MG / PIBRENTASVIR 40 MG ORAL TABLET [MAVYRET]?

    GLECAPREVIR 100 MG / PIBRENTASVIR 40 MG ORAL TABLET [MAVYRET] has 22,898 side effect reports in this SymPedia dataset.

  • What year does the GLECAPREVIR 100 MG / PIBRENTASVIR 40 MG ORAL TABLET [MAVYRET] reporting data start?

    The reporting data on this page starts in 2025.

  • What years are included in the yearly chart for GLECAPREVIR 100 MG / PIBRENTASVIR 40 MG ORAL TABLET [MAVYRET]?

    The yearly chart on this page includes data from 1018 to 2025.